Your browser doesn't support javascript.
loading
MHC-II Signature Correlates With Anti-Tumor Immunity and Predicts anti-PD-L1 Response of Bladder Cancer.
Yi, Ruibin; Hong, Shuo; Zhang, Yueming; Lin, Anqi; Ying, Haoxuan; Zou, Weidong; Wang, Qiongyao; Wei, Ting; Cheng, Quan; Zhu, Weiliang; Luo, Peng; Zhang, Jian.
Afiliação
  • Yi R; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Hong S; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Zhang Y; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Lin A; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Ying H; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Zou W; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Wang Q; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Wei T; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Cheng Q; Department of Neurosurgery, Xiangya Hospital, Center South University, Changsha, China.
  • Zhu W; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Luo P; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Zhang J; Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Front Cell Dev Biol ; 10: 757137, 2022.
Article em En | MEDLINE | ID: mdl-35223828
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Cell Dev Biol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Cell Dev Biol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China